Zomer Monica Tessmann, Ribeiro Reitan, Trippia Carlos Henrique, Cavalcanti Teresa Cristina Santos, Hayashi Renata Mieko, Kondo William
Centro Médico-Hospitalar Sugisawa, Curitiba (PR), Brasil.
Rev Bras Ginecol Obstet. 2013 Jun;35(6):262-7. doi: 10.1590/s0100-72032013000600005.
To correlate preoperative serum cancer antigen 125 (Ca-125) levels and laparoscopic findings in women with pelvic pain symptoms suggestive of endometriosis.
A retrospective study was conducted including all women with pelvic pain symptoms suspected for endometriosis operated by laparoscopy from January 2010 to March 2013. Patients were divided into 2 groups according to preoperative Ca-125 level (<35 U/mL and ≥ 35 U/mL). Subsequently, patients with ovarian endometriomas were excluded and a further analysis was conducted again according to the preoperative Ca-125 level. The following parameters were compared between groups: presence of ovarian endometrioma, presence and number of deep infiltrating endometriosis (DIE) lesions and American Society for Reproductive Medicine score. The statistical analysis was performed with Statistica version 8.0, using the Fisher exact test, Student's t-test and Mann-Whitney test, when needed. A p value of <0.05 was considered to be statistically significant.
During the study period, a total of 350 women were submitted to laparoscopic treatment of endometriosis. One hundred thirty patients (37.1%) had Ca-125 ≥ 35 U/mL and 220 (62.9%) had Ca-12<35 U/mL. The presence of ovarian endometriomas (47.7 versus 15.9%), DIE lesions (99.6 versus 78.6%) and intestinal DIE lesions (60 versus 30.9%) was more frequent, and the AFSr score was higher (34 versus 6) in the former group. In the second analysis, excluding the patients with ovarian endometriomas (≥ 35 U/mL=68 patients and <35 U/mL=185 patients), similar results were obtained. The presence of DIE lesions (91.2 versus 76.2%), intestinal DIE lesions (63.2 versus 25.4%), bladder DIE lesions (20.6 versus 4.8%) and ureteral DIE lesions (7.3 versus 1.6%) was more frequent, and the AFSr score was higher (10 versus 6) in the Ca-125 ≥ 35 U/mL group.
Investigation for DIE is mandatory in women with pelvic pain symptoms suggestive of endometriosis with a preoperative Ca-125 level ≥ 35 U/mL, especially when an ovarian endometrioma is not present.
探讨术前血清癌抗原125(Ca-125)水平与有子宫内膜异位症相关盆腔疼痛症状女性患者腹腔镜检查结果之间的相关性。
进行一项回顾性研究,纳入2010年1月至2013年3月间因盆腔疼痛症状疑似子宫内膜异位症而接受腹腔镜手术的所有女性患者。根据术前Ca-125水平(<35 U/mL和≥35 U/mL)将患者分为两组。随后,排除卵巢子宫内膜异位囊肿患者,并再次根据术前Ca-125水平进行进一步分析。比较两组之间的以下参数:卵巢子宫内膜异位囊肿的存在情况、深部浸润性子宫内膜异位症(DIE)病灶的存在情况及数量,以及美国生殖医学学会评分。必要时,使用Statistica 8.0软件进行统计分析,采用Fisher精确检验、Student t检验和Mann-Whitney检验。p值<0.05被认为具有统计学意义。
在研究期间,共有350名女性接受了子宫内膜异位症的腹腔镜治疗。130例患者(37.1%)Ca-125≥35 U/mL,220例患者(62.9%)Ca-125<35 U/mL。卵巢子宫内膜异位囊肿的存在(47.7%对15.9%)、DIE病灶(99.6%对78.6%)和肠道DIE病灶(60%对30.9%)在前一组中更为常见,且美国生殖医学学会修订版(AFSr)评分更高(34对6)。在第二项分析中,排除卵巢子宫内膜异位囊肿患者(≥35 U/mL组=68例患者,<35 U/mL组=185例患者)后,得到了类似的结果。Ca-125≥35 U/mL组中DIE病灶的存在(91.2%对76.2%)、肠道DIE病灶(63.2%对25.4%)、膀胱DIE病灶(20.6%对4.8%)及输尿管DIE病灶(7.3%对1.6%)更为常见,且AFSr评分更高(10对6)。
对于有子宫内膜异位症相关盆腔疼痛症状且术前Ca-125水平≥35 U/mL的女性,尤其是不存在卵巢子宫内膜异位囊肿的患者,必须对DIE进行检查。